- Clinical Assistant Professor, Global Health
- Co-Founder, Hurone AI
- Affiliate Member, Vaccines & Infectious Disease Division, Fred Hutch Cancer Center
Select from the following:
Kingsley I. Ndoh, MD, MPH is a physician-entrepreneur and Clinical Assistant Professor of Global Health at the University of Washington. He is the Founder and CEO of Hurone AI, a healthcare technology company building patient navigation and care orchestration infrastructure for complex diseases, starting with oncology.
Hurone AI partners with leading U.S. academic and community cancer centers, to deploy governed, enterprise-grade AI to improve patient engagement and outcomes between visits and enables scalable care delivery. The company is focused on transforming fragmented, between-visit care into a continuous, intelligent system that health systems can operate, govern, and reimburse.
Prior to Hurone, Dr. Ndoh led large-scale market-shaping initiatives at BVGH where he structured and executed national- and system-level access agreements between governments and global pharmaceutical companies. His work has spanned healthcare system design, commercialization strategy, and public-private partnerships across the U.S. and international Cancer Centers.
Dr. Ndoh has advised federal efforts on cancer innovation, most notably the U.S. President’s Cancer Panel on the role of navigation and AI in improving cancer care delivery. He is an Affiliate member at the Fred Hutch Cancer Center.
He holds an MD from the University of Jos and an MPH in Global Health from the University of Washington.
- MD (University of Jos)
- MPH (University of Washington)
- Hausa
- Igbo
- Cancer
- Epidemiology
- Mobile Health (mHealth)
- Non-Communicable Diseases
- Research
Kizub D, Gralow J, Zujewski J, Ndoh K., Soko U, Dvaladze A. Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern African. J of Glob Onc, 2020 Jan; 19: P219.
Murallitharan Munisamy, Kingsley Ndoh, Ahmed Abdelbadee, Isthar Espejo, Florence Manjuh, Alexandra Tamas, Omolola Salako, and Felipe Roitberg. Adapting Cancer Civil Society Organizations to Accelerate COVID-19 Vaccinations in People Living With Cancer in Low- and Middle-Income Countries—A Commentary. JCO Global Oncology 2021 :7, 1194-1198
Eze U, Ndoh K, Kanmodi K. COVID-19 Crises in Africa: Revisiting the Contributing Factors. Annals of Public Health Issues. Vol. 1: 2720-1961 2021
Dankwa-Mullan I, Ndoh K, Akogo D, Rocha HAL, Juaçaba SF. Artificial Intelligence and Cancer Health Equity: Bridging the Divide or Widening the Gap. Current Oncology Reports. Published online January 3, 2025. doi:https://doi.org/10.1007/s11912-024-01627-1
Ngwa W, Addai BW, Adewole I, et al. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. The Lancet Oncology. 2022;0(0). doi:https://doi.org/10.1016/S1470-2045(21)00720-8
Ndoh K, Ahmed A, Yates R, et al. Cancer control funding in Nigeria: A case for universal health coverage. Journal of Cancer Policy. 2022;32:100335. doi:https://doi.org/10.1016/j.jcpo.2022.100335